Company Filing History:
1 out of 832,761 Years Active: 1999
Title: Matthew Thomas Holden: Innovator in Biosynthetic Pathways
Introduction
Matthew Thomas Holden is a distinguished inventor based at the University of Warwick in Coventry, GB. He has made significant contributions to the field of biosynthetic pathways, particularly in relation to carbapenem production. His innovative work has implications for antibiotic development and microbial resistance.
Latest Patents
Matthew Thomas Holden holds a patent related to "Genes involved in the biosynthetic pathway of carbapenem." This patent represents a crucial advancement in understanding how certain genes contribute to the synthesis of this important class of antibiotics. He has 1 patent to his name, showcasing his commitment to innovation in the field.
Career Highlights
Throughout his career, Holden has focused on the intersection of genetics and microbiology. His research has been pivotal in exploring how genetic components can be manipulated to enhance antibiotic production. His work not only contributes to academic knowledge but also has practical applications in healthcare.
Collaborations
Matthew has collaborated with notable colleagues, including George Peacock Salmond and Simon James McGowan. These partnerships have enriched his research and expanded the impact of his findings in the scientific community.
Conclusion
In summary, Matthew Thomas Holden is a prominent inventor whose work on the biosynthetic pathways of carbapenem has the potential to influence antibiotic development significantly. His contributions to the field are invaluable and reflect his dedication to advancing scientific knowledge.